$CNMD
CONMED Corp Stock $cnmd

$cnmd Overview Financials Valuation SEC Filings Company Website

2012 Q1 Form 10-Q Financial Statement

#000081695612000010 Filed on May 01, 2012

Income Statement

Concept	2012 Q1	2011 Q1
Revenue	$194.3M	$183.5M
YoY Change	5.92%	4.02%
Cost Of Revenue	$93.41M	$87.73M
YoY Change	6.46%	3.7%
Gross Profit	$100.9M	$95.72M
YoY Change	5.43%	4.27%
Gross Profit Margin	51.93%	52.18%
Selling, General & Admin	$74.81M	$70.08M
YoY Change	6.75%	-0.74%
% of Gross Profit	74.13%	73.21%
Research & Development	$7.095M	$7.681M
YoY Change	-7.63%	-0.25%
% of Gross Profit	7.03%	8.02%
Depreciation & Amortization	$4.688M	$4.416M
YoY Change	6.16%	-52.0%
% of Gross Profit	4.65%	4.61%
Operating Expenses	$83.89M	$78.45M
YoY Change	6.93%	0.32%
Operating Profit	$17.02M	$17.26M
YoY Change	-1.4%	26.98%
Interest Expense	$1.437M	$1.805M
YoY Change	-20.39%	-164.46%
% of Operating Profit	8.44%	10.46%
Other Income/Expense, Net
YoY Change
Pretax Income	$15.59M	$14.36M
YoY Change	8.5%	33.0%
Income Tax	$5.617M	$5.369M
% Of Pretax Income	36.04%	37.38%
Net Earnings	$9.968M	$8.995M
YoY Change	10.82%	22.9%
Net Earnings / Revenue	5.13%	4.9%
Basic Earnings Per Share	$0.36	$0.32
Diluted Earnings Per Share	$0.35	$0.31
COMMON SHARES
Basic Shares Outstanding	28.03M shares	28.26M shares
Diluted Shares Outstanding	28.48M shares	28.70M shares

Balance Sheet

Concept	2012 Q1	2011 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$19.50M	$17.90M
YoY Change	8.94%	79.0%
Cash & Equivalents	$19.45M	$17.94M
Short-Term Investments
Other Short-Term Assets	$26.10M	$21.60M
YoY Change	20.83%	-16.6%
Inventory	$163.4M	$171.2M
Prepaid Expenses
Receivables	$142.4M	$147.3M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$351.3M	$358.0M
YoY Change	-1.88%	1.39%
LONG-TERM ASSETS
Property, Plant & Equipment	$141.0M	$141.1M
YoY Change	-0.05%	-1.05%
Goodwill	$234.8M
YoY Change
Intangibles	$193.6M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$155.8M	$9.900M
YoY Change	1473.74%	33.78%
Total Long-Term Assets	$725.3M	$634.4M
YoY Change	14.33%	-0.77%
TOTAL ASSETS
Total Short-Term Assets	$351.3M	$358.0M
Total Long-Term Assets	$725.3M	$634.4M
Total Assets	$1.077B	$992.4M
YoY Change	8.48%	0.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$27.09M	$24.10M
YoY Change	12.4%	-12.68%
Accrued Expenses	$20.90M	$21.20M
YoY Change	-1.42%	-4.93%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$54.22M	$111.5M
YoY Change	-51.37%	216.76%
Total Short-Term Liabilities	$165.8M	$180.5M
YoY Change	-8.12%	70.44%
LONG-TERM LIABILITIES
Long-Term Debt	$139.0M	$71.80M
YoY Change	93.53%	-58.71%
Other Long-Term Liabilities	$89.25M	$28.40M
YoY Change	214.25%	14.06%
Total Long-Term Liabilities	$228.2M	$100.2M
YoY Change	127.74%	-49.6%
TOTAL LIABILITIES
Total Short-Term Liabilities	$165.8M	$180.5M
Total Long-Term Liabilities	$228.2M	$100.2M
Total Liabilities	$489.8M	$391.4M
YoY Change	25.15%	-4.09%
SHAREHOLDERS EQUITY
Retained Earnings	$360.2M
YoY Change
Common Stock	$313.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$71.99M
YoY Change
Treasury Stock Shares
Shareholders Equity	$586.7M	$601.0M
YoY Change
Total Liabilities & Shareholders Equity	$1.077B	$992.4M
YoY Change	8.48%	0.0%

Cashflow Statement

Concept	2012 Q1	2011 Q1
OPERATING ACTIVITIES
Net Income	$9.968M	$8.995M
YoY Change	10.82%	22.9%
Depreciation, Depletion And Amortization	$4.688M	$4.416M
YoY Change	6.16%	-52.0%
Cash From Operating Activities	$7.629M	$20.70M
YoY Change	-63.14%	-260.47%
INVESTING ACTIVITIES
Capital Expenditures	$6.424M	$4.143M
YoY Change	55.06%	-225.55%
Acquisitions
YoY Change
Other Investing Activities	-$64.10M	-$100.0K
YoY Change	64000.0%	-98.04%
Cash From Investing Activities	-$70.54M	-$4.215M
YoY Change	1573.55%	-49.82%
FINANCING ACTIVITIES
Cash Dividend Paid	$4.300M
YoY Change
Common Stock Issuance & Retirement, Net	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$55.82M	-$11.71M
YoY Change	-576.53%	-154.73%
NET CHANGE
Cash From Operating Activities	$7.629M	$20.70M
Cash From Investing Activities	-$70.54M	-$4.215M
Cash From Financing Activities	$55.82M	-$11.71M
Net Change In Cash	-$7.095M	$4.772M
YoY Change	-248.68%	4672.0%
FREE CASH FLOW
Cash From Operating Activities	$7.629M	$20.70M
Capital Expenditures	$6.424M	$4.143M
Free Cash Flow	$1.205M	$16.56M
YoY Change	-92.72%	-272.47%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2011Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	21162000	USD
CY2012Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	27088000	USD
CY2012Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	142351000	USD
CY2011Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	135641000	USD
CY2011Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	6470000	USD
CY2012Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	4991000	USD
CY2012Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25271000	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-26348000	USD
CY2012Q1	us-gaap	Acquired Finite Lived Intangible Asset Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetWeightedAverageUsefulLife	29	Y
CY2012Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	323486000	USD
CY2011Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	321994000	USD
CY2011Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	4830000	USD
CY2012Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	7124000	USD
CY2012Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2011Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1094000	USD
CY2012Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2012Q1	dei	Entity Registrant Name EntityRegistrantName	CONMED CORP
CY2011Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.00
CY2012Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.15
CY2012Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.15
CY2011Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1623000	USD
CY2012Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1932000	USD
CY2011Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	700000	shares
CY2012Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	400000	shares
CY2012Q1	us-gaap	Assets Assets	1076560000	USD
CY2011Q4	us-gaap	Assets Assets	935594000	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	356724000	USD
CY2012Q1	us-gaap	Assets Current AssetsCurrent	351278000	USD
CY2012Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	704000	USD
CY2011Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19454000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26048000	USD
CY2011Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17939000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12417000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-6594000	USD
CY2011Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	5522000	USD
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2012Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31299203	shares
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31299203	shares
CY2012Q1	us-gaap	Common Stock Value CommonStockValue	313000	USD
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	313000	USD
CY2011Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	12024000	USD
CY2012Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	11045000	USD
CY2011Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	87734000	USD
CY2012Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	93405000	USD
CY2011Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4625000	USD
CY2012Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2735000	USD
CY2012Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	10951000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	10283000	USD
CY2012Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	2422000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	2389000	USD
CY2011Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	92785000	USD
CY2012Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	95791000	USD
CY2011Q1	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-366000	USD
CY2012Q1	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-732000	USD
CY2012Q1	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	6500000	USD
CY2012Q1	us-gaap	Defined Benefit Plan Estimated Future Employer Contributions In Next Fiscal Year DefinedBenefitPlanEstimatedFutureEmployerContributionsInNextFiscalYear	2700000	USD
CY2011Q1	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	1057000	USD
CY2012Q1	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	1131000	USD
CY2011Q1	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	1096000	USD
CY2012Q1	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	859000	USD
CY2012Q1	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	525000	USD
CY2011Q1	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	475000	USD
CY2012Q1	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	65000	USD
CY2011Q1	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	70000	USD
CY2012Q1	us-gaap	Depreciation Depreciation	4688000	USD
CY2011Q1	us-gaap	Depreciation Depreciation	4416000	USD
CY2012Q1	us-gaap	Derivative Assets DerivativeAssets	2488000	USD
CY2011Q4	us-gaap	Derivative Assets DerivativeAssets	5083000	USD
CY2012Q1	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	2146000	USD
CY2011Q4	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	4662000	USD
CY2012Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	342000	USD
CY2011Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	421000	USD
CY2011Q1	us-gaap	Dividends Payable Amount DividendsPayableAmount	0	USD
CY2012Q1	us-gaap	Dividends Payable Amount DividendsPayableAmount	4328000	USD
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.36
CY2011Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.32
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2011Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.31
CY2011Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	750000	USD
CY2012Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	501000	USD
CY2012Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	20863000	USD
CY2011Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	31142000	USD
CY2011Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	79480000	USD
CY2012Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	81412000	USD
CY2012Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense FiniteLivedIntangibleAssetsAmortizationExpense	7726000	USD
CY2011Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1200000	USD
CY2012Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	400000	USD
CY2012Q1	us-gaap	Future Amortization Expense Year Five FutureAmortizationExpenseYearFive	6390000	USD
CY2012Q1	us-gaap	Future Amortization Expense Year Four FutureAmortizationExpenseYearFour	6390000	USD
CY2012Q1	us-gaap	Future Amortization Expense Year One FutureAmortizationExpenseYearOne	7503000	USD
CY2012Q1	us-gaap	Future Amortization Expense Year Three FutureAmortizationExpenseYearThree	6491000	USD
CY2012Q1	us-gaap	Future Amortization Expense Year Two FutureAmortizationExpenseYearTwo	6880000	USD
CY2012Q1	us-gaap	Goodwill Goodwill	234794000	USD
CY2011Q4	us-gaap	Goodwill Goodwill	234815000	USD
CY2012Q1	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	21000	USD
CY2012Q1	us-gaap	Gross Profit GrossProfit	100911000	USD
CY2011Q1	us-gaap	Gross Profit GrossProfit	95716000	USD
CY2011Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1917000	USD
CY2012Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1106000	USD
CY2011Q1	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent	-1046000	USD
CY2011Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	14364000	USD
CY2012Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	15585000	USD
CY2012Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5617000	USD
CY2011Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5369000	USD
CY2011Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1782000	USD
CY2012Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2601000	USD
CY2011Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-90000	USD
CY2012Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5618000	USD
CY2011Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	333000	USD
CY2012Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1232000	USD
CY2011Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-7442000	USD
CY2012Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-10446000	USD
CY2012Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2764000	USD
CY2011Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-420000	USD
CY2011Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-11705000	USD
CY2012Q1	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	2339000	USD
CY2012Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-5032000	USD
CY2011Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	2448000	USD
CY2012Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	193643000	USD
CY2011Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	195531000	USD
CY2011Q1	us-gaap	Interest Expense InterestExpense	1805000	USD
CY2012Q1	us-gaap	Interest Expense InterestExpense	1437000	USD
CY2011Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	100588000	USD
CY2012Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	98591000	USD
CY2011Q4	us-gaap	Inventory Net InventoryNet	168438000	USD
CY2012Q1	us-gaap	Inventory Net InventoryNet	163390000	USD
CY2012Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	48756000	USD
CY2011Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	52351000	USD
CY2011Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	15499000	USD
CY2012Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	16043000	USD
CY2011Q1	us-gaap	Legal Fees LegalFees	0	USD
CY2012Q1	us-gaap	Legal Fees LegalFees	1011000	USD
CY2012Q1	us-gaap	Liabilities Liabilities	489835000	USD
CY2011Q4	us-gaap	Liabilities Liabilities	362523000	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	935594000	USD
CY2012Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1076560000	USD
CY2012Q1	us-gaap	Liabilities Current LiabilitiesCurrent	165845000	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	131184000	USD
CY2012Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	54219000	USD
CY2011Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	54557000	USD
CY2011Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	88952000	USD
CY2012Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	138952000	USD
CY2012Q1	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Operations</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CONMED Corporation (“CONMED”, the “Company”, “we” or “us”) is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures and monitoring.  The Company’s products serve the clinical areas of arthroscopy, powered surgical instruments, electrosurgery, cardiac monitoring single-uses, endosurgery and endoscopic technologies.  They are used by surgeons and physicians in a variety of specialties including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology.</font></div></div>
CY2011Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-11713000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	55816000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-70540000	USD
CY2011Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4215000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7629000	USD
CY2011Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	20700000	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	9968000	USD
CY2011Q1	us-gaap	Net Income Loss NetIncomeLoss	8995000	USD
CY2012Q1	us-gaap	Operating Expenses OperatingExpenses	83889000	USD
CY2011Q1	us-gaap	Operating Expenses OperatingExpenses	78453000	USD
CY2011Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	17263000	USD
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	17022000	USD
CY2011Q4	us-gaap	Other Assets OtherAssets	6948000	USD
CY2012Q1	us-gaap	Other Assets OtherAssets	153391000	USD
CY2011Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-231000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-462000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent	-1561000	USD
CY2011Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	3844000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2176000	USD
CY2012Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	58684000	USD
CY2011Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	17853000	USD
CY2011Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	49602000	USD
CY2012Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	89247000	USD
CY2012Q1	us-gaap	Other Nonrecurring Expense OtherNonrecurringExpense	1988000	USD
CY2011Q1	us-gaap	Other Nonrecurring Expense OtherNonrecurringExpense	694000	USD
CY2012Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6424000	USD
CY2011Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4143000	USD
CY2011Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2012Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2012Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2011Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2011Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2011Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15132000	USD
CY2011Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16314000	USD
CY2012Q1	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	50000000	USD
CY2011Q1	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	USD
CY2011Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1287000	USD
CY2012Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	5345000	USD
CY2011Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	337000	USD
CY2012Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	809000	USD
CY2012Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3696000	USD
CY2011Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3433000	USD
CY2010Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3363000	USD
CY2011Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3618000	USD
CY2012Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1047000	USD
CY2011Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1075000	USD
CY2012Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1125000	USD
CY2011Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1145000	USD
CY2012Q1	us-gaap	Profit Loss ProfitLoss	9968000	USD
CY2011Q1	us-gaap	Profit Loss ProfitLoss	8995000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	139187000	USD
CY2012Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	141032000	USD
CY2011Q1	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	13337000	USD
CY2012Q1	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	338000	USD
CY2012Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7095000	USD
CY2011Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7681000	USD
CY2012Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	360185000	USD
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	354439000	USD
CY2011Q1	us-gaap	Sales Revenue Net SalesRevenueNet	183450000	USD
CY2012Q1	us-gaap	Sales Revenue Net SalesRevenueNet	194316000	USD
CY2012Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	74806000	USD
CY2011Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	70078000	USD
CY2011Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1026000	USD
CY2012Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1183000	USD
CY2012Q1	us-gaap	Stockholders Equity StockholdersEquity	586725000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	573071000	USD
CY2011Q4	us-gaap	Treasury Stock Number Of Shares Held TreasuryStockNumberOfSharesHeld	3358078	shares
CY2012Q1	us-gaap	Treasury Stock Number Of Shares Held TreasuryStockNumberOfSharesHeld	3115110	shares
CY2012Q1	us-gaap	Treasury Stock Value TreasuryStockValue	71988000	USD
CY2011Q4	us-gaap	Treasury Stock Value TreasuryStockValue	77327000	USD
CY2011Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	440000	shares
CY2012Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	455000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28484000	shares
CY2011Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28701000	shares
CY2011Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28261000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28029000	shares
CY2011Q4	cnmd	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	275011000	USD
CY2012Q1	cnmd	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	275055000	USD
CY2012Q1	cnmd	Joint Development And Distribution Agreement Accumulated Amortization JointDevelopmentAndDistributionAgreementAccumulatedAmortization	1500000	USD
CY2012Q1	cnmd	Joint Development And Distribution Agreement Conditional Payment Amount JointDevelopmentAndDistributionAgreementConditionalPaymentAmount	84000000	USD
CY2012Q1	cnmd	Joint Development And Distribution Agreement Conditional Payment Period JointDevelopmentAndDistributionAgreementConditionalPaymentPeriod	P4Y
CY2012Q1	cnmd	Joint Development And Distribution Agreement Gross Carrying Amount JointDevelopmentAndDistributionAgreementGrossCarryingAmount	148100000	USD
CY2012Q1	cnmd	Joint Development And Distribution Agreement Term JointDevelopmentAndDistributionAgreementTerm	P25Y
CY2012Q1	cnmd	Joint Development And Distribution Agreement Up Front Payment JointDevelopmentAndDistributionAgreementUpFrontPayment	63000000	USD
CY2012Q1	cnmd	Number Of Employees Joining Company NumberOfEmployeesJoiningCompany	35	Employees
CY2012Q1	cnmd	Number Of Principal Operating Segments NumberOfPrincipalOperatingSegments	5	Segments
CY2012Q1	cnmd	Payments Related To Business Acquisitions And Distribution Agreement PaymentsRelatedToBusinessAcquisitionsAndDistributionAgreement	64116000	USD
CY2011Q1	cnmd	Payments Related To Business Acquisitions And Distribution Agreement PaymentsRelatedToBusinessAcquisitionsAndDistributionAgreement	72000	USD
CY2012Q1	cnmd	Product Liability Contingency Insurance Aggregate Annual Amount ProductLiabilityContingencyInsuranceAggregateAnnualAmount	25000000	USD
CY2012Q1	cnmd	Product Liability Contingency Insurance Amount Per Incident ProductLiabilityContingencyInsuranceAmountPerIncident	25000000	USD
CY2012Q1	cnmd	Product Warranty Accrual Term ProductWarrantyAccrualTerm	P1Y
CY2012Q1	dei	Amendment Flag AmendmentFlag	false
CY2012Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2012Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2012Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
CY2012Q1	dei	Document Period End Date DocumentPeriodEndDate	2012-03-31
CY2012Q1	dei	Document Type DocumentType	10-Q
CY2012Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000816956
CY2012Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	28289720	shares

Files In Submission

Name	View Source	Status
0000816956-12-000010-index-headers.html	Edgar Link	pending
0000816956-12-000010-index.html	Edgar Link	pending
0000816956-12-000010.txt	Edgar Link	pending
0000816956-12-000010-xbrl.zip	Edgar Link	pending
cnmd-20120331.xml	Edgar Link	completed
cnmd-20120331.xsd	Edgar Link	pending
cnmd-20120331_cal.xml	Edgar Link	unprocessable
cnmd-20120331_def.xml	Edgar Link	unprocessable
cnmd-20120331_lab.xml	Edgar Link	unprocessable
cnmd-20120331_pre.xml	Edgar Link	unprocessable
cnmd3311210q.htm	Edgar Link	pending
cnmd33112ex311.htm	Edgar Link	pending
cnmd33112ex312.htm	Edgar Link	pending
cnmd33112ex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CNMD
CONMED Corp Stock $cnmd

2012 Q1 Form 10-Q Financial Statement

#000081695612000010 Filed on May 01, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNMD CONMED Corp Stock $cnmd

2012 Q1 Form 10-Q Financial Statement

#000081695612000010 Filed on May 01, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CNMD
CONMED Corp Stock $cnmd